HIV/HCV合并感染患者中胰岛素抵抗与聚乙二醇干扰素（Peg-IFN）联合利巴韦林（RBV）的HCV病毒学应答情况。 - Suppr | 超能文献

Insulin resistance and HCV virologic response to peg-interferons (Peg-IFN) with ribavirin (RBV) in HIV/HCV co-infected patients.

作者信息

Donato C, Cingolani A, Pinnetti C, De Luca A

出版信息

J Hepatol. 2010 Feb;52(2):306-7. doi: 10.1016/j.jhep.2009.10.028. Epub 2009 Nov 10.

DOI:10.1016/j.jhep.2009.10.028

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Insulin resistance and HCV virologic response to peg-interferons (Peg-IFN) with ribavirin (RBV) in HIV/HCV co-infected patients.HIV/HCV合并感染患者中胰岛素抵抗与聚乙二醇干扰素（Peg-IFN）联合利巴韦林（RBV）的HCV病毒学应答情况。

J Hepatol. 2010 Feb;52(2):306-7. doi: 10.1016/j.jhep.2009.10.028. Epub 2009 Nov 10.

2

Distinct hepatitis C virus kinetics in HIV-infected patients treated with ribavirin plus either pegylated interferon alpha2a or alpha2b.在接受利巴韦林联合聚乙二醇化干扰素α2a或α2b治疗的HIV感染患者中，丙型肝炎病毒的动力学特征各异。

Antivir Ther. 2008;13(4):511-7.

3

INCIDENCE OF TUBERCULOSIS AMONG HIV/HCV CO-INFECTED PATIENTS RECEIVING HEPATITIS C TREATMENT WITH PEGYLATED INTERFERON AND RIBAVIRIN IN GEORGIA.格鲁吉亚接受聚乙二醇干扰素和利巴韦林治疗丙型肝炎的HIV/HCV合并感染患者的结核病发病率

Georgian Med News. 2016 Mar(252):10-5.

4

Insulin resistance is not a relevant predictor of sustained virological response to pegylated interferon plus ribavirin in HIV/HCV co-infected patients.胰岛素抵抗并非HIV/HCV合并感染患者对聚乙二醇化干扰素加利巴韦林持续病毒学应答的相关预测指标。

J Hepatol. 2009 Apr;50(4):684-92. doi: 10.1016/j.jhep.2008.10.032. Epub 2008 Dec 29.

5

Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients.利巴韦林在丙型肝炎病毒（HCV）/人类免疫缺陷病毒（HIV）合并感染患者实现HCV治疗早期病毒学应答中的关键作用。

J Viral Hepat. 2007 Jun;14(6):387-91. doi: 10.1111/j.1365-2893.2006.00806.x.

6

[Treatment with pegylated interferon and ribavirin in patients co-infected by human immunodeficiency virus and hepatitis C virus].[聚乙二醇干扰素和利巴韦林治疗人类免疫缺陷病毒与丙型肝炎病毒合并感染患者]

Rev Clin Esp. 2007 Mar;207(3):150-1; author reply 151-2.

7

PegIFN/ribavirin during acute HCV coinfection.急性丙型肝炎病毒合并感染时的聚乙二醇干扰素/利巴韦林

IAPAC Mon. 2004 Jul;10(7):260-1.

8

Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients.聚乙二醇干扰素-α-2b对HIV/HCV合并感染患者中HIV和HCV的差异抗病毒作用。

AIDS. 2007 Sep 12;21(14):1855-65. doi: 10.1097/QAD.0b013e32825eaba7.

9

Health-related quality of life and severity of fatigue in HIV/HCV co-infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirin.在聚乙二醇干扰素联合利巴韦林抗病毒治疗前后，HIV/HCV 合并感染患者的健康相关生活质量和疲劳严重程度。

Liver Int. 2014 Jan;34(1):69-77. doi: 10.1111/liv.12253. Epub 2013 Jul 29.

10

Treatment of hepatitis C in patients with haemophilia - the Israeli National Hemophilia Center experience.血友病患者丙型肝炎的治疗——以色列国家血友病中心的经验

Haemophilia. 2008 Mar;14(2):336-42. doi: 10.1111/j.1365-2516.2007.01633.x. Epub 2008 Jan 16.

引用本文的文献

1

Pilot study of pioglitazone before HCV retreatment in HIV/HCV genotype 1-infected subjects with insulin resistance and previous nonresponse to peginterferon and ribavirin therapy: A5239.胰岛素抵抗且既往对聚乙二醇干扰素和利巴韦林治疗无应答的 HIV/HCV 基因型 1 感染患者中，预先使用吡格列酮治疗 HCV 再治疗：A5239 研究。

J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):345-9. doi: 10.1097/QAI.0000000000000073.